Management of Uncomplicated Non-Purulent Cellulitis
For uncomplicated non-purulent cellulitis in adults without drug allergies, treat with oral beta-lactam antibiotics targeting streptococci and methicillin-sensitive Staphylococcus aureus (MSSA) for 5 days, combined with elevation of the affected limb and treatment of predisposing factors. 1
First-Line Antibiotic Selection
The primary pathogens in non-purulent cellulitis are β-hemolytic streptococci and MSSA, making beta-lactam antibiotics the appropriate first-line choice 1, 2:
- Cephalexin 500 mg orally four times daily is the most commonly recommended agent 1, 3
- Alternative options include:
Do not routinely add MRSA coverage (such as trimethoprim-sulfamethoxazole) for uncomplicated non-purulent cellulitis, as adding TMP-SMX to cephalexin provides no additional benefit in clinical cure rates (83.5% vs 85.5%, difference -2.0%) 3. MRSA coverage is only indicated for specific risk factors including penetrating trauma, known MRSA colonization, injection drug use, or systemic inflammatory response syndrome (SIRS) 1.
Treatment Duration
Five days of antibiotic therapy is sufficient for uncomplicated cellulitis 1, 4:
- A randomized trial demonstrated that 5 days of levofloxacin achieved 98% clinical success, equivalent to 10 days of therapy 4
- Extend treatment only if the infection has not improved within the 5-day period 1
Essential Non-Pharmacological Management
Elevation of the affected extremity is a critical component of treatment 1. This recommendation carries strong evidence and should be implemented immediately.
Examine and treat interdigital toe spaces carefully 1:
- Look for fissuring, scaling, or maceration between toes
- Treating tinea pedis and toe web abnormalities eradicates pathogen colonization and reduces recurrence risk 1, 5
Address predisposing factors during the acute phase 1, 5:
- Edema management
- Venous insufficiency treatment
- Obesity counseling
- Eczema or other underlying cutaneous disorders
- Skin barrier integrity optimization
Adjunctive Corticosteroid Therapy
Consider adding systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adult patients 1. This carries a weak recommendation with moderate-quality evidence, but may provide symptomatic benefit without increasing adverse outcomes 6.
Outpatient vs. Inpatient Management
Treat as an outpatient if the patient lacks:
- SIRS criteria
- Altered mental status
- Hemodynamic instability 1
Hospitalize if:
- Concern exists for deeper or necrotizing infection
- Poor adherence to therapy is anticipated
- Severe immunocompromise is present
- Outpatient treatment is failing 1
An early warning score (EWS) ≥3 on presentation predicts longer hospital stays and 30-day readmission, which can guide admission decisions 7.
Common Pitfalls to Avoid
Do not over-treat with broad-spectrum antibiotics. Beta-lactam therapy demonstrates equivalent or superior efficacy compared to non-beta-lactam antibiotics (failure rate 14.7% vs 17.0%), with significantly fewer adverse effects requiring discontinuation (0.5% vs 2.2%) 8.
Do not obtain routine cultures. Microbiological diagnosis is obtained in only 15% of cases, and empiric therapy based on clinical presentation is appropriate 9. When cultures are obtained, S. aureus (48%) and Group A Streptococcus (17%) predominate 7.
Do not delay compression therapy if edema is present. Recent evidence shows that early compression (within 24 hours of antibiotic initiation) accelerates CRP reduction and symptom improvement without worsening inflammation 10.
Recurrence Prevention
For patients with 3-4 episodes per year despite treating predisposing factors, initiate prophylactic antibiotics 1:
- Oral penicillin or erythromycin twice daily for 4-52 weeks, OR
- Intramuscular benzathine penicillin every 2-4 weeks
- Continue prophylaxis as long as predisposing factors persist 1